New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
05:50 EDTMDSOMedidata Solutions upgraded to Buy from Neutral at B. Riley
B. Riley upgraded Medidata Solutions to Buy citing yesterday's pullback in shares. The firm lowered its price target for shares to $49 from $53.
News For MDSO From The Last 14 Days
Check below for free stories on MDSO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 4, 2014
10:29 EDTMDSOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:49 EDTMDSOMedidata Solutions initiated with an Overweight at Morgan Stanley
Target $56.
07:21 EDTMDSOMedidata can obtain major new platform customers, says Stifel
Noting that Medidata (MDSO) partners with Veeva, Stifel believes that a number of Veeva (VEEV) customers could become Medidata platform customers, especially if they already use Medidata for R&D and clinical trial solutions. The firm identifies Merck (MRK), Gilead (GILD), and Teva (TEVA) as companies that may become platform clients for Medidata. Stifel keeps a $55 price target and Buy rating on Medidata.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use